Related Experiment Video
Updated: May 11, 2026

Experimental Approaches to Tissue Engineering
Published on: August 30, 2007
Continuing to strengthen FDA's science approach to emerging technologies
Rachael Anatol1, Steven Bauer, Suzanne Epstein
1Emerging Technology Programs, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD, USA.
Abstract:
Emerging technologies result when advances and innovation in technology lead to discoveries. Often emerging technologies stimulate novel research in medical product development that contribute to new approaches to manufacturing and can improve the quality of products. By supporting investments in agency coordination, staff training and professional development, regulatory science research, stakeholder engagement, and enhancing opportunities for expert input, the U.S. Food and Drug Administration plays a critical role in translating innovations into novel safe and effective medical products that improve the public health.
Related Concept Videos
Drug Regulation
FDA Approved Drugs: Changes to Approved Drugs
Clinically Relevant Drug Product Specifications: Methods of Establishment
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Drug Control Governance: Regulatory Bodies and Their Impact
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
